December 22, 2008

ELI LILLY: Reviewing Claims Over Cymbalta(R) Patents Validity

COMPANIES: Eli Lilly & Co
Subscribe

Eli Lilly and Co. is reviewing the allegations by generic drug manufacturers that the Company’s patents that relate to the Cymbalta(R) product are either invalid or not infringed.

The Company has…

TO CONTINUE READING,LOGIN or
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Indiana | United States